CTOs on the Move

CareFinders Total Care

www.carefinders.org

 
Care Finders Total Care provides the highest level of home care and personalized service to patients of all ages including children, adults and the elderly. Care Finders Total Care provides reliable Certified Home Health Aides who will make sure that while they provide the care you need, your independence, dignity and religious customs are maintained, regardless of your disability or illness.
  • Number of Employees: 1K-5K
  • Annual Revenue: $1-10 Million
  • www.carefinders.org
  • 171 Main Street Second Floor
    Hackensack, NJ USA 07601
  • Phone: 201.342.5122

Executives

Name Title Contact Details

Similar Companies

BaySport

"With corporate headquarters in Los Gatos, BaySport, Inc. has been serving the Bay Area since 1984. The organization has evolved from providing ""on-site"" physical examination programs for corporations, to developing sports medicine centers with a strong"

Physicians Reimbursement Systs

Physicians Reimbursement Systs is a Denver, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Curve Health

Curve Health is senior care without walls. Founded in April of 2020 on a platform that`s reduced patient transfers from Skilled Nursing Facilities (SNFs) to Emergency Departments by 50%+, Curve advances connected senior care by bridging the silos that hinder healthcare delivery today; enabling physicians to remotely care for patients in SNFs, at home, in ambulances or wherever they may be. Curve combines telemedicine, a health information exchange, predictive analytics and smart billing into a single platform, resulting in higher quality care + significant return on investment, while ensuring the most seamless patient experience.

Neuralstem

Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of major depressive disorder (MDD). Neuralstem is expecting to launch a Phase II study for MDD in 2015. Neuralstem`s first stem cell therapy product, NSI-566, a spinal cord-derived neural stem cell line, is in ongoing clinical trials to treat amyotrophic lateral sclerosis (ALS, or Lou Gehrig`s disease), for which it has received orphan status designation by the FDA. Dosing in a phase IIa trial was completed in July, 2014. The next trial is anticipated to commence in 2015. In addition to ALS, the company is conducting an NSI-566 Phase I trial in chronic spinal cord injury, with NSI-566 clinical development also underway to treat ischemic

EnviroMerica

EnviroMerica is a Dublin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.